MODERNA, PFIZER TO EXPAND COVID-19 VACCINE STUDY TO KIDS AGES 5 – 11
Tue 27 July 2021: Moderna Inc is in talks with US regulators to expand the size of an ongoing trial testing its COVID-19 vaccines in children aged between five and 11, the drugmaker said on Monday. The objective of the discussion with the US Food and Drug Administration is to enroll a larger safety database, which […]
Continue Reading
